Full-Service Commercialization
Accelerating the path to full market potential
Underpinned by our market-leading Commercial capabilities and Kinetic™, our commercial platform that streamlines and optimizes commercialization activities, Full-Service Commercialization enables biopharmaceutical companies to leverage our vast experience, predictive insights, capabilities, global infrastructure and deep local market expertise with the goal of scaling-up, reducing risk and getting to market faster.
Helping you increase the probability of commercial success
Early-stage biopharma companies have traditionally had limited options for getting their first asset to market. In most cases, they pursue deals with larger partners and lose or limit rights to their asset, or become a fully integrated company through heavy investment and a great deal of risk.
Thanks to our Full-Service Commercialization solution, there is now a third option: the leading integrated commercial delivery model. This pharma commercialization services model aims to increase efficiency, scale and speed by utilizing existing global infrastructure and significant expertise within Syneos Health® and — importantly — enables customers to retain control of their assets longer to keep future options open.
See how Full-Service Commercialization helped these companies reach their potential:
Sound strategy coupled with tightly coordinated execution
We meet our customers exactly where they are in the drug commercialization process to create sound strategy coupled with tightly controlled execution – all with the highest levels of support from industry veterans who have been executive leaders in nearly every commercial function in biopharma.
We focus our integrated solutions on your business objectives and design them to supplement your capabilities with a customized configuration of drug commercialization services. A Syneos Health Commercialization Lead works in close collaboration with the commercialization lead in your organization, orchestrating all outsourced activity and gaining you targeted, efficient, cost-effective access to the full breadth and depth of our resources and capabilities.
Full-Service Commercialization is the commercial concierge emerging companies need that can help reduce risk, manage costs and optimize performance. Our hard-earned knowledge, agility and unrivaled expertise are our superpowers and, by extension, yours.
More Reasons Why
For established brands: maximizing revenue by creating the right promotional mix for established brands
Transitioning a drug brand from the growth to maturity stage presents special challenges and opportunities. The challenges can be significant, but the opportunities are, too – bolstered by HCP familiarity, the availability of data on how the product works in the real-world setting, and uptake analytics that can be leveraged to refine future strategies.
An established drug brand still has the potential to be a source of revenue, but needs a more efficient promotional model to maximize bottom-line results.
We approach the promotion of established pharmaceutical brands with an innovative, modular full-service marketing solution that integrates advanced data science, digital communications and resource deployment together with your existing infrastructure to realize your established brand’s full potential.
For non-core assets: solving for unique resourcing challenges
Compared to your organization’s core assets – i.e., assets in priority therapeutic areas with dedicated infrastructure and subject matter expertise resourced internally – non-core assets present a unique set of resourcing challenges, including lack of investment; inefficiencies and high costs; and lack of a clear strategic path forward to optimize development.
The benefits of our solution?
- Expertise in your non-core therapeutic area or category by tapping our global talent
- Full suite of product development services including Clinical Development, Medical & Commercialization
- Dedicated leadership as a single point-of-contact with your organization
- Integrated support customized to your strategic goals and timelines
- Optionality to out-license, divest or transfer infrastructure as desired
Partnering with purpose to deliver integrated drug commercialization services to drive performance
We provide integrated pharmaceutical commercialization solutions designed around your own unique asset and corporate strategy. When you work with Syneos One, our extensive commercialization capabilities – including award-winning, full-service agency capabilities – become yours. Together we build an agile and streamlined partnership that aims to create:
- Less complexity, less risk and a clear roadmap to commercial success grounded in a precise plan for all the variables unique to your asset
- Lower infrastructure investment and up to 20% savings by using a contract commercial model
- The ability to scale up or down to rapidly respond to market dynamics, opportunities or challenges
- The opportunity to expand the model across multiple assets over time, utilizing the same framework and a partner who understands your organization
- Customized, fully integrated solutions that bring deep therapeutic expertise, novel strategy and flawless execution
- A collaborative approach that provides unique access to data and experts to “read through the noise” in every therapeutic category
A globalization accelerator that puts faster, smarter go-to-market optionality in your hands
Full-Service Commercialization is also the ideal solution for biopharma companies seeking to launch in new markets, where they face multiple challenges that can make or break their success including resource constraints, risk exposure, the complexity of uncharted territory, and nonalignment across siloed and divergent stakeholders. We partner with purpose, focused on your performance, with an unmatched suite of globalization capabilities at your disposal, from strategic planning and communications to deployment solutions.
Related Content
Looking for exclusive insight?
